Module 9 2021

23/03/2021

TOPRA MSc Module 9: Registration of Biological, Biotechnology and Advanced Therapy Products Regulation of Vaccines (Lecture 10)

Wednesday 24 March, 2021

Andrew Deavin, Director, Global Regulatory Affairs, GSK

ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY PROFESSION

1

Disclosure Statement

Andrew Deavin is an employee of the GSK group of companies and holds shares in GSK The opinions expressed in this presentation and on the following slides are solely those of the presenter and not necessarily those of GSK

2

1